Transfar Capital
Hangzhouetransfar.com
Overview
Transfar Capital is the investment arm of Transfar Group, a Chinese conglomerate with business in chemicals, logistics, agriculture, and technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arnatar Therapeutics | Dec 2024 | Series A | Co-investor |
| SineuGene Therapeutics | Aug 2024 | VC Round | Co-investor |
| Anatar, Inc. | Apr 2024 | Series A | Co-investor |
| Santo Therapeutics | Dec 2023 | Angel | Lead |
| Fujian Deer Technology Corp. | Aug 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
